Edition:
United States

Orexo AB (ORX.ST)

ORX.ST on Stockholm Stock Exchange

64.80SEK
13 Dec 2018
Change (% chg)

-- (--)
Prev Close
64.80kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
182,166
52-wk High
75.60kr
52-wk Low
28.10kr

Chart for

About

Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for respiratory and inflammatory diseases. The Company has four commercialized products, several projects... (more)

Overall

Beta: 1.62
Market Cap(Mil.): kr1,976.86
Shares Outstanding(Mil.): 34.56
Dividend: --
Yield (%): --

Financials

  ORX.ST Industry Sector
P/E (TTM): 17.71 29.45 30.88
EPS (TTM): 3.23 -- --
ROI: 21.47 14.34 13.80
ROE: 31.25 15.85 15.29

Orexo soars after winning opioid drug appeal against Teva

A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB's lawsuit accusing a unit of Israel's Teva Pharmaceutical Industries Ltd of infringing a patent for its opioid addiction drug Zubsolv.

Sep 10 2018

UPDATE 2-Orexo soars after winning opioid drug appeal against Teva

Sept 10 A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB's lawsuit accusing a unit of Israel's Teva Pharmaceutical Industries Ltd of infringing a patent for its opioid addiction drug Zubsolv.

Sep 10 2018

Earnings vs. Estimates